differences between semaglutide and tirzepatide vs. Ozempic: Comparing Diabetes Treatments & Weight Loss Benefits Tirzepatide vs. Semaglutide for Weight

Key results at 80 weeks: Participants on the 4 mg dose lost an average of 47.2 lbs (19.0%) Participants on the 12 mg dose lost an average of 70.3 lbs (28.3%) 45.3% of participants on the 12 mg dose achieved at least 30% weight loss a level historically associated with bariatric surgery outcomes The 4 mg dose showed a lower rate of discontinuation due to adverse events than even placebo In a study extension to 104 weeks, participants with a starting BMI of 35 or higher who received 12 mg lost up to an average of 85.0 lbs (30.3%)

Psychiatry 4 , e458

Many people obtain prescriptions through telehealth platforms that partner with compounding pharmacies

This low dose allows doctors to observe how the body responds in the initial weeks

Novartis.

An Ozempic pen, for example, lasts one month, says Krezdorn